Drug Type Small molecule drug |
Synonyms KNP 503, KNP503 |
Target |
Action inhibitors |
Mechanism SHP2 inhibitors(Src homology phosphotyrosyl phosphatase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | South Korea | 05 Jul 2024 | |
| Glioblastoma | Preclinical | South Korea | 05 Jul 2024 | |
| Non-Small Cell Lung Cancer | Preclinical | South Korea | 05 Jul 2024 |





